@article {Escribano82, author = {Amparo Escribano and M{\'o}nica Amor and Sara Pastor and Silvia Castillo and Francisco Sanz and Pilar Codo{\~n}er-Franch and Francisco Das{\'\i}}, title = {Decreased glutathione and low catalase activity contribute to oxidative stress in children with α-1 antitrypsin deficiency}, volume = {70}, number = {1}, pages = {82--83}, year = {2015}, doi = {10.1136/thoraxjnl-2014-205898}, publisher = {BMJ Publishing Group Ltd}, abstract = {Background Recent investigations in animal models have revealed oxidative stress and oxidative damage in the pathogenesis of alpha-1 antitrypsin deficiency (AATD). However, no data are available on the oxidative stress status and antioxidant enzyme activity in these patients. This study was aimed to analyse the oxidative stress profile and enzymatic antioxidant defence mechanisms in children with AATD. Methods Oxidative stress parameters and the activity of the main antioxidant enzymes were prospectively measured in serum of fifty-one children diagnosed with AATD and thirty-eight control individuals. Results Oxidative stress was increased in the serum of children with intermediate- (MZ; SZ) and high-risk (ZZ) phenotypes for developing AATD-related emphysema and/or liver disease. When compared with the control group, intermediate- and high-risk groups showed significantly lower total glutathione and reduced glutathione levels, decreased catalase activity and increased glutathione peroxidase activity leading to an accumulation of hydrogen peroxide that would explain the significantly increased levels of oxidative stress biomarkers observed in these patients. No differences were observed between the control (MM) and the low-risk (MS; SS) groups. A gradation in oxidative stress parameters was observed when patients were compared among themselves, in that the expression of the Z allele produces a higher oxidative stress status in homozygous (ZZ) than in heterozygous (MZ; SZ) patients. Conclusions Increased oxidative stress, together with reduced antioxidant defence are involved in the pathophysiology of AATD at early stages, opening up a new rationale for the use of antioxidant therapies in the treatment of the disease.}, issn = {0040-6376}, URL = {https://thorax.bmj.com/content/70/1/82}, eprint = {https://thorax.bmj.com/content/70/1/82.full.pdf}, journal = {Thorax} }